PMA device
Instat Collagen Absorbable Hemostat
ETHICON, Inc. · Agent, Absorbable Hemostatic, Collagen Based (LMF, Class III) · First FDA decision Jun 22, 2004, newest Nov 28, 2007Surgical bleeding and hemostasis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Instat"
MAUDE reports
0
Brand "Instat", since 2015
PubMed studies
200
Mentioning "Instat"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Instat Collagen Absorbable Hemostat
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- INSTAT COLLAGEN ABSORBABLE HEMOSTATPMA supplement
P830079-S017 · Decided Nov 28, 2007 · 180 days after receipt · Normal 180 Day Track
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
- INSTAT COLLAGEN HEMOSTATPMA supplement
P830079-S016 · Decided Jul 22, 2005 · 28 days after receipt · Normal 180 Day Track No User Fee
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
- INSTAT COLLAGEN HEMOSTATPMA supplement
P830079-S015 · Decided Jun 22, 2004 · 55 days after receipt · Normal 180 Day Track No User Fee
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Instat", any status and sponsor, newest update first.
No registered device study names "Instat".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Instat", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LMF
1,445 reports: 207 malfunction, 1,171 injury, 61 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Integra LifeSciences Corporation
Z-1288-2013 · Started Mar 28, 2013 · Posted by FDA May 10, 2013
Reason given: Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.
Cause as FDA categorized it: Process control · Device type: Agent, Absorbable Hemostatic, Collagen Based (LMF)
Integra LifeSciences Corporation
Z-1289-2013 · Started Mar 28, 2013 · Posted by FDA May 10, 2013
Reason given: Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.
Cause as FDA categorized it: Process control · Device type: Agent, Absorbable Hemostatic, Collagen Based (LMF)
Published research
The most relevant PubMed records for "Instat"[tiab]. The summary above synthesizes these.
- [Not Available].
Salem BO, Elshehawi DM, Elnaggar GA · Braz Dent J · 2022English Abstract
- Postpartum psychosis: risk factors identification.
Upadhyaya SK, Sharma A, Raval CM · N Am J Med Sci · 2014
- Beyond physical ability-predicting women's football performance from psychological factors.
Pettersen SD, Martinussen M, Handegård BH, et al. · Front Psychol · 2023
- [Analysis of genotypes and phenotypes of three children with Cornelia de Lange syndrome].
Zhao L, Zhang Q, Zhou B, et al. · Zhonghua Yi Xue Yi Chuan Xue Za Zhi · 2023English Abstract
- Factors affecting match running performance in elite soccer: Analysis of UEFA Champions League matches.
Modric T, Versic S, Stojanovic M, et al. · Biol Sport · 2023
- Factors Affecting the Running Performance of Soccer Teams in the Turkish Super League.
Plakias S, Michailidis Y · Sports (Basel) · 2024
- Does the Number of Substitutions Used during the Matches Affect the Recovery Status and the Physical and Technical Performance of Elite Women's Soccer?
Kobal R, Aquino R, Carvalho L, et al. · Int J Environ Res Public Health · 2022Research Support, Non-U.S. Gov't
- Histopathological Study of Spectrum of Lesions of Uterine Cervix.
Jadhav A, Sanklecha V, Natekar A, et al. · J Midlife Health · 2023
- Correlations of passes and playing formations with technical-tactical elements during the 2022 FIFA World Cup.
Michailidis Y, Nenos I, Metaxas I, et al. · J Sports Med Phys Fitness · 2023
- Prevalence of sacroiliitis among patients referred for hip MR arthrography.
Giaconi J, Waldman L, Robinson J, et al. · Skeletal Radiol · 2022
- Impact of Temperature and Atmospheric Pressure on Hospitalizations of Patients Presenting With Acute Coronary Syndrome.
Shuka N, Cabeli A, Simoni L, et al. · Cureus · 2024
- Analysis of Goal Scoring Patterns in the 2018 FIFA World Cup.
Kubayi A · J Hum Kinet · 2020
Other devices of this type
Also filed under product code LMF.
- SURGIFOAM® Absorbable Gelatin SpongeFerrosan Meidcal Devices A/S · PMA 2026
- Floseal Hemostatic MatrixBaxter Healthcare Corp · PMA 2015
- Vitagel Surgical HemostatStryker Corp. · PMA 2013
- SURGIFLO Hemostatic Matrix Kit with ThrombinFerrosan Meidcal Devices A/S · PMA 2025
- Helistat Absorbable Collagen Hemostatic Sponge/OraFOAM Absorbable Collagen Hemostatic SpongeIntegra LifeSciences Corporation · PMA 2019
- Avitene Flowable Collagen HemostatDavol Inc., Sub. C. R. Bard, Inc. · PMA 2025
- Collastat Absorbable Collagen Hemostatic AgentsIntegra LifeSciences Corporation · PMA 2009
- Floseal (R) Matrix Hemostatic Sealant and Proceed (Tm) Hemostatic SealantBaxter Healthcare Corp · PMA 2001
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.